$401.59
0.01%
Nasdaq, Sep 22, 11:26 am EDT. Market open.
ISIN
US46120E6023
Symbol
ISRG

Intuitive Surgical Target price 2026 - Analyst rating & recommendation

Intuitive Surgical Classifications & Recommendation

Buy
73%
Hold
25%
Sell
3%

Intuitive Surgical Price Target

Target Price $494.70
Price $401.65
Potential 23.17%
Number of Estimates 33
33 Analysts have issued a price target Intuitive Surgical 2027 . The average Intuitive Surgical target price is $494.70. This is 23.17% higher than the current stock price. The highest price target is $719.25 79.07% , the lowest is $327.24 18.53% .
A rating was issued by 40 analysts: 29 Analysts recommend Intuitive Surgical to buy, 10 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Intuitive Surgical stock has an average upside potential 2027 of 23.17% . Most analysts recommend the Intuitive Surgical stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion $ 10.06 12.00
20.51% 19.21%
EBITDA Margin 29.37% 45.64%
3.98% 55.40%
Net Margin 28.38% 32.48%
2.04% 14.46%

36 Analysts have issued a sales forecast Intuitive Surgical 2026 . The average Intuitive Surgical sales estimate is

$12.0b
unlock
. This is
8.73% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$12.6b 13.77%
unlock
, the lowest is
$11.3b 2.48%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $10.1b 20.51%
2026
$12.0b 19.21%
unlock
2027
$13.5b 12.75%
unlock
2028
$15.3b 13.03%
unlock
2029
$16.2b 5.82%
unlock
2030
$18.0b 10.95%
unlock
2031
$18.6b 3.65%
unlock
2032
$20.1b 8.24%
unlock
2033
$21.9b 8.61%
unlock

27 Analysts have issued an Intuitive Surgical EBITDA forecast 2026. The average Intuitive Surgical EBITDA estimate is

$5.5b
unlock
. This is
58.64% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.8b 68.78%
unlock
, the lowest is
$4.9b 43.11%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $3.0b 25.30%
2026
$5.5b 85.25%
unlock
2027
$6.1b 10.87%
unlock
2028
$6.9b 13.23%
unlock
2029
$7.7b 12.42%
unlock
2030
$8.7b 12.76%
unlock

EBITDA Margin

2025 29.37% 3.98%
2026
45.64% 55.40%
unlock
2027
44.88% 1.67%
unlock
2028
44.95% 0.16%
unlock
2029
47.76% 6.25%
unlock
2030
48.54% 1.63%
unlock

37 Intuitive Surgical Analysts have issued a net profit forecast 2026. The average Intuitive Surgical net profit estimate is

$3.9b
unlock
. This is
24.14% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$4.1b 31.17%
unlock
, the lowest is
$3.7b 17.79%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $2.9b 22.97%
2026
$3.9b 36.43%
unlock
2027
$4.4b 12.01%
unlock
2028
$4.9b 13.07%
unlock
2029
$5.5b 10.52%
unlock
2030
$6.1b 12.51%
unlock

Net Margin

2025 28.38% 2.04%
2026
32.48% 14.46%
unlock
2027
32.26% 0.68%
unlock
2028
32.27% 0.03%
unlock
2029
33.71% 4.46%
unlock
2030
34.18% 1.39%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ 7.87 11.01
22.59% 39.90%
P/E 36.48
EV/Sales 11.38

37 Analysts have issued a Intuitive Surgical forecast for earnings per share. The average Intuitive Surgical EPS is

$11.01
unlock
. This is
25.40% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$11.63 32.46%
unlock
, the lowest is
$10.45 19.02%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $7.87 22.59%
2026
$11.01 39.90%
unlock
2027
$12.33 11.99%
unlock
2028
$13.94 13.06%
unlock
2029
$15.41 10.55%
unlock
2030
$17.34 12.52%
unlock
2031
$18.63 7.44%
unlock
2032
$19.92 6.92%
unlock
2033
$21.51 7.98%
unlock

P/E ratio

Current 45.75 25.24%
2026
36.48 20.26%
unlock
2027
32.57 10.72%
unlock
2028
28.80 11.58%
unlock
2029
26.06 9.51%
unlock
2030
23.16 11.13%
unlock

Based on analysts' sales estimates for 2026, the Intuitive Surgical stock is valued at an EV/Sales of

11.38
unlock
and an P/S ratio of
11.83
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 12.38 23.39%
2026
11.38 8.05%
unlock
2027
10.10 11.31%
unlock
2028
8.93 11.53%
unlock
2029
8.44 5.50%
unlock
2030
7.61 9.87%
unlock
2031
7.34 3.52%
unlock
2032
6.78 7.62%
unlock
2033
6.24 7.93%
unlock

P/S ratio

Current 12.86 25.23%
2026
11.83 8.03%
unlock
2027
10.49 11.31%
unlock
2028
9.28 11.53%
unlock
2029
8.77 5.50%
unlock
2030
7.90 9.87%
unlock
2031
7.63 3.52%
unlock
2032
7.04 7.62%
unlock
2033
6.49 7.93%
unlock

Current Intuitive Surgical Upgrades & Downgrades

Analyst Rating Action Date
BTIG
Buy
Buy
Unchanged Sep 08 2026
Oppenheimer
Perform
Outperform
Upgrade Aug 12 2026
HSBC
Buy
Hold
Downgrade Jul 30 2026
Evercore ISI Group
In-Line
In-Line
Unchanged Jul 17 2026
Wells Fargo
Overweight
Overweight
Unchanged Jul 17 2026
Baird
Outperform
Outperform
Unchanged Jul 17 2026
BTIG
Buy
Buy
Unchanged Jul 17 2026
Analyst Rating Date
Unchanged
BTIG:
Buy
Buy
Sep 08 2026
Upgrade
Oppenheimer:
Perform
Outperform
Aug 12 2026
Downgrade
HSBC:
Buy
Hold
Jul 30 2026
Unchanged
Evercore ISI Group:
In-Line
In-Line
Jul 17 2026
Unchanged
Wells Fargo:
Overweight
Overweight
Jul 17 2026
Unchanged
Baird:
Outperform
Outperform
Jul 17 2026
Unchanged
BTIG:
Buy
Buy
Jul 17 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today